The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis
Context: The metabolic syndrome (MetS) is a cluster of metabolic abnormalities that
increase the risk for type 2 diabetes mellitus and vascular disease. The common …
increase the risk for type 2 diabetes mellitus and vascular disease. The common …
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications
G Arnaldi, T Mancini, G Tirabassi, L Trementino… - Journal of …, 2012 - Springer
Cushing's syndrome (CS) is a clinical condition resulting from chronic exposure to
glucocorticoid excess. As a consequence, hypercortisolism contributes significantly to the …
glucocorticoid excess. As a consequence, hypercortisolism contributes significantly to the …
Cushing's syndrome: overview of clinical presentation, diagnostic tools and complications
M Barbot, M Zilio, C Scaroni - … practice & research Clinical endocrinology & …, 2020 - Elsevier
Cushing's syndrome (CS) is a severe condition that results from chronic exposure to
elevated circulating cortisol levels; it is a rare but potentially life-threating condition …
elevated circulating cortisol levels; it is a rare but potentially life-threating condition …
Clinical and biochemical manifestations of Cushing's
G Ntali, A Grossman, N Karavitaki - Pituitary, 2015 - Springer
Introduction Cushing's syndrome is associated with a number of clinical manifestations and
co-morbidities which may not resolve even after long-term remission leading to excessive …
co-morbidities which may not resolve even after long-term remission leading to excessive …
Comorbidities in Mild Autonomous Cortisol Secretion–A Clinical Review of Literature
A Czapla-Iskrzycka… - Experimental and …, 2022 - thieme-connect.com
Mild autonomous cortisol secretion (mACS) is a state of cortisol excess usually associated
with existence of adrenal incidentaloma. Because of the lack of symptoms of the disease, the …
with existence of adrenal incidentaloma. Because of the lack of symptoms of the disease, the …
[HTML][HTML] Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome
X He, JW Findling, RJ Auchus - Pituitary, 2022 - Springer
Abstract Purpose: Literature regarding endogenous Cushing syndrome (CS) largely focuses
on the challenges of diagnosis, subtyping, and treatment. The enigmatic phenomenon of …
on the challenges of diagnosis, subtyping, and treatment. The enigmatic phenomenon of …
The metabolic syndrome and cardiovascular risk in Cushing's syndrome
R Pivonello, A Faggiano, G Lombardi… - Endocrinology and …, 2005 - endo.theclinics.com
Cushing's syndrome (CS) is characterized by a series of systemic complications, including
abdominal obesity, systemic arterial hypertension, impairment of glucose tolerance …
abdominal obesity, systemic arterial hypertension, impairment of glucose tolerance …
Mechanisms in endocrinology: tissue-specific activation of cortisol in Cushing's syndrome
SA Morgan, ZK Hassan-Smith… - European journal of …, 2016 - academic.oup.com
Glucocorticoids are widely prescribed for their anti-inflammatory properties, but have
'Cushingoid'side effects including visceral obesity, muscle myopathy, hypertension, insulin …
'Cushingoid'side effects including visceral obesity, muscle myopathy, hypertension, insulin …
Subclinical Cushing's syndrome
M De Leo, A Cozzolino, A Colao, R Pivonello - Best practice & research …, 2012 - Elsevier
The routine use of abdominal procedure has significantly increased the incidental finding of
adrenal masses. The prevalence of these tumors, commonly defined as adrenal …
adrenal masses. The prevalence of these tumors, commonly defined as adrenal …
Harmful effects of functional hypercortisolism: a working hypothesis
G Tirabassi, M Boscaro, G Arnaldi - Endocrine, 2014 - Springer
Functional hypercortisolism (FH) is caused by conditions able to chronically activate
hypothalamic–pituitary–adrenal axis and usually occurs in cases of major depression …
hypothalamic–pituitary–adrenal axis and usually occurs in cases of major depression …